Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HIL7
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0043085 | positive regulation of catalytic activity | 4 | 1 |
GO:0043087 | regulation of GTPase activity | 5 | 1 |
GO:0043547 | positive regulation of GTPase activity | 6 | 1 |
GO:0044093 | positive regulation of molecular function | 3 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0050790 | regulation of catalytic activity | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051336 | regulation of hydrolase activity | 4 | 1 |
GO:0051345 | positive regulation of hydrolase activity | 5 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065009 | regulation of molecular function | 2 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0090630 | activation of GTPase activity | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0003924 | GTPase activity | 7 | 5 |
GO:0003925 | G protein activity | 2 | 5 |
GO:0016462 | pyrophosphatase activity | 5 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 5 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 5 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 5 |
GO:0098772 | molecular function regulator activity | 1 | 5 |
GO:0005096 | GTPase activator activity | 4 | 1 |
GO:0008047 | enzyme activator activity | 3 | 1 |
GO:0030234 | enzyme regulator activity | 2 | 1 |
GO:0030695 | GTPase regulator activity | 4 | 1 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 1 |
GO:0140677 | molecular function activator activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 301 | 303 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.276 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.302 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.265 |
DEG_APCC_DBOX_1 | 271 | 279 | PF00400 | 0.441 |
DOC_CYCLIN_yClb1_LxF_4 | 171 | 177 | PF00134 | 0.398 |
DOC_MAPK_MEF2A_6 | 198 | 205 | PF00069 | 0.173 |
DOC_MAPK_MEF2A_6 | 243 | 251 | PF00069 | 0.356 |
DOC_MAPK_MEF2A_6 | 53 | 60 | PF00069 | 0.376 |
DOC_MAPK_NFAT4_5 | 198 | 206 | PF00069 | 0.173 |
DOC_PP4_FxxP_1 | 176 | 179 | PF00568 | 0.295 |
DOC_USP7_UBL2_3 | 276 | 280 | PF12436 | 0.434 |
DOC_WW_Pin1_4 | 290 | 295 | PF00397 | 0.422 |
DOC_WW_Pin1_4 | 80 | 85 | PF00397 | 0.315 |
LIG_14-3-3_CanoR_1 | 91 | 99 | PF00244 | 0.210 |
LIG_Actin_WH2_2 | 285 | 303 | PF00022 | 0.250 |
LIG_BIR_III_2 | 254 | 258 | PF00653 | 0.202 |
LIG_BRCT_BRCA1_1 | 133 | 137 | PF00533 | 0.232 |
LIG_BRCT_BRCA1_1 | 56 | 60 | PF00533 | 0.320 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.338 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.415 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.435 |
LIG_LIR_Gen_1 | 180 | 190 | PF02991 | 0.308 |
LIG_LIR_Gen_1 | 268 | 278 | PF02991 | 0.279 |
LIG_LIR_Gen_1 | 282 | 289 | PF02991 | 0.460 |
LIG_LIR_Gen_1 | 311 | 320 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 44 | 52 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 8 | 19 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 111 | 115 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.243 |
LIG_LIR_Nem_3 | 180 | 185 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 21 | 25 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 268 | 273 | PF02991 | 0.286 |
LIG_LIR_Nem_3 | 282 | 286 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 8 | 14 | PF02991 | 0.471 |
LIG_PDZ_Class_1 | 319 | 324 | PF00595 | 0.571 |
LIG_Pex14_1 | 277 | 281 | PF04695 | 0.333 |
LIG_Pex14_2 | 151 | 155 | PF04695 | 0.367 |
LIG_Pex14_2 | 204 | 208 | PF04695 | 0.280 |
LIG_Pex14_2 | 219 | 223 | PF04695 | 0.295 |
LIG_PTB_Apo_2 | 226 | 233 | PF02174 | 0.261 |
LIG_SH2_PTP2 | 22 | 25 | PF00017 | 0.206 |
LIG_SH2_SRC | 72 | 75 | PF00017 | 0.154 |
LIG_SH2_STAP1 | 195 | 199 | PF00017 | 0.253 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.244 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.244 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.284 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.326 |
LIG_UBA3_1 | 269 | 276 | PF00899 | 0.432 |
LIG_WRC_WIRS_1 | 220 | 225 | PF05994 | 0.276 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.371 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.415 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.378 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.266 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.154 |
MOD_CK2_1 | 177 | 183 | PF00069 | 0.370 |
MOD_CK2_1 | 33 | 39 | PF00069 | 0.471 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.267 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.448 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.552 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.324 |
MOD_N-GLC_1 | 126 | 131 | PF02516 | 0.353 |
MOD_N-GLC_1 | 65 | 70 | PF02516 | 0.154 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.375 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.433 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.295 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.367 |
MOD_NEK2_1 | 300 | 305 | PF00069 | 0.540 |
MOD_NEK2_1 | 315 | 320 | PF00069 | 0.333 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.419 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.376 |
MOD_PIKK_1 | 82 | 88 | PF00454 | 0.320 |
MOD_PKA_2 | 242 | 248 | PF00069 | 0.364 |
MOD_PKA_2 | 300 | 306 | PF00069 | 0.369 |
MOD_Plk_1 | 41 | 47 | PF00069 | 0.232 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.362 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.375 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.334 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.369 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.375 |
MOD_Plk_4 | 315 | 321 | PF00069 | 0.491 |
MOD_ProDKin_1 | 290 | 296 | PF00069 | 0.421 |
MOD_ProDKin_1 | 80 | 86 | PF00069 | 0.315 |
TRG_DiLeu_BaEn_2 | 41 | 47 | PF01217 | 0.154 |
TRG_DiLeu_BaLyEn_6 | 254 | 259 | PF01217 | 0.441 |
TRG_ENDOCYTIC_2 | 22 | 25 | PF00928 | 0.306 |
TRG_ER_diArg_1 | 300 | 302 | PF00400 | 0.437 |
TRG_ER_diArg_1 | 89 | 91 | PF00400 | 0.276 |
TRG_Pf-PMV_PEXEL_1 | 290 | 295 | PF00026 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1N7 | Leptomonas seymouri | 62% | 100% |
A0A0S4ITU5 | Bodo saltans | 40% | 79% |
A0A1X0NLM2 | Trypanosomatidae | 26% | 92% |
A0A1X0P1K5 | Trypanosomatidae | 47% | 81% |
A0A3S7X3S6 | Leishmania donovani | 83% | 100% |
A0A422NJ84 | Trypanosoma rangeli | 28% | 77% |
A0A422NJE8 | Trypanosoma rangeli | 26% | 93% |
A4HQC7 | Leishmania braziliensis | 25% | 76% |
A4I5W2 | Leishmania infantum | 82% | 100% |
C9ZR83 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 82% |
E9B157 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q4Q0F2 | Leishmania major | 23% | 78% |
Q4Q709 | Leishmania major | 81% | 100% |
Q6PBU5 | Danio rerio | 24% | 91% |
V5B7A5 | Trypanosoma cruzi | 50% | 100% |
V5BT66 | Trypanosoma cruzi | 29% | 79% |